Statement by Ralph G. Neas, President and CEO, Generic Pharmaceutical Association, on Senate Vote to Restore FDA Sequestered User Fees

Published Online: Thursday, January 16, 2014
PRESS RELEASE

WASHINGTON DC, (January 16, 2014) — Today, the U.S. Senate joined the House of Representatives in voting to restore $85 million in Food and Drug Administration (FDA) sequestered user fees, reflecting bipartisan recognition of the critical need to ensure the agency has the resources required to carry out its mission, including the review and approval of affordable generic medicines and biosimilars.

GPhA would especially like to congratulate Senate Agriculture and FDA Appropriations Subcommittee Chair Mark Pryor and Ranking Member Roy Blunt for their unwavering commitment to restoring industry-supported FDA user fees and ensuring that millions of Americans have timely access to more affordable generic medicines.

View the January 15 press release here.
Latest Articles
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.
Chronic kidney disease incidence has grown faster than many of its common comorbidities such as diabetes and hypertension, and medications may be an underappreciated driver of this growth.
President Barack Obama’s fiscal year 2017 budget proposal calls for an additional $1.1 billion to combat the nation’s spiraling opioid epidemic.
Baxter International is voluntarily recalling intravenous solution due to leaking containers and the potential for particulate matter.
Latest Issues
$auto_registration$